- Home
- SBT vs NLSP Comparison
SBT vs NLSP Comparison
Compare SBT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBT
- NLSP
- Stock Information
- Founded
- SBT 1984
- NLSP 2015
- Country
- SBT United States
- NLSP Switzerland
- Employees
- SBT N/A
- NLSP N/A
- Industry
- SBT Savings Institutions
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- SBT Finance
- NLSP Health Care
- Exchange
- SBT Nasdaq
- NLSP Nasdaq
- Market Cap
- SBT 243.3M
- NLSP 243.8M
- IPO Year
- SBT 2017
- NLSP 2021
- Fundamental
- Price
- SBT $4.48
- NLSP $5.28
- Analyst Decision
- SBT
- NLSP
- Analyst Count
- SBT 0
- NLSP 0
- Target Price
- SBT N/A
- NLSP N/A
- AVG Volume (30 Days)
- SBT 60.5K
- NLSP 26.9K
- Earning Date
- SBT 10-23-2024
- NLSP 10-18-2024
- Dividend Yield
- SBT N/A
- NLSP N/A
- EPS Growth
- SBT N/A
- NLSP N/A
- EPS
- SBT 0.13
- NLSP N/A
- Revenue
- SBT $69,973,000.00
- NLSP N/A
- Revenue This Year
- SBT N/A
- NLSP N/A
- Revenue Next Year
- SBT $6.68
- NLSP N/A
- P/E Ratio
- SBT $34.79
- NLSP N/A
- Revenue Growth
- SBT N/A
- NLSP N/A
- 52 Week Low
- SBT $4.40
- NLSP $4.08
- 52 Week High
- SBT $6.01
- NLSP $40.60
- Technical
- Relative Strength Index (RSI)
- SBT 29.40
- NLSP 45.46
- Support Level
- SBT $4.40
- NLSP $4.72
- Resistance Level
- SBT $4.53
- NLSP $5.50
- Average True Range (ATR)
- SBT 0.10
- NLSP 0.64
- MACD
- SBT -0.00
- NLSP 0.05
- Stochastic Oscillator
- SBT 21.62
- NLSP 41.67
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.